Alessandro de Luca, Head of Digital Enterprise Solutions, and Emre Özcan, SVP, Global Head of Digital Health and Devices, discuss how the convergence of science and technology is redefining the future of pharma.

Pharma stands at an inflection point. The fusion of advanced science, digital technology, and real-world data is transforming how treatments are conceived, delivered, and experienced. Digital therapeutics are at the heart of this shift—moving the industry from a pure drug provider to a holistic therapy partner focused on measurable, continuous outcomes.

The conversation explores how digital innovation is reshaping clinical development, commercial models, and patient engagement. It examines the opportunities and challenges in integrating evidence-based digital interventions alongside pharmacological therapies, setting the foundation for the next generation of hybrid, personalized care.

Speakers

Roberto Ascione

President, Health Innovation, EVERSANA 

Alessandro De Luca

Head of Digital Enterprise Solutions and Group CIO, Merck Group 

Emre Ozcan

SVP, Global Head of Digital Health & Devices 

Merck Group